![David Chang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Chang
Fondateur chez
ALLOGENE THERAPEUTICS, INC.
Fortune : 13 M $ au 31/05/2026
Profil
Le Dr David D. Chang est président, directeur général et directeur d'Allogene Therapeutics, Inc. et directeur et partenaire de risque de Vida Ventures LLC, partenaire de risque de Two River Consulting LLC, observateur du conseil d'administration de Cell Design Labs, Inc. et partenaire de risque de Two River Group Holdings LLC et partenaire de risque de VV Manager LLC. Il siège au conseil d'administration d'Allogene Therapeutics, Inc, Peloton Therapeutics, Inc, Vida Ventures LLC, A2 Biotherapeutics, Inc et IconOVir Bio, Inc. Le Dr Chang a précédemment occupé les postes de directeur médical et de vice-président de la recherche et du développement chez Kite Pharma, Inc. et de vice-président du développement mondial chez Amgen, Inc. et de professeur associé à la David Geffen School of Medicine. Il a obtenu son diplôme de premier cycle au Massachusetts Institute of Technology et un doctorat à l'université de Stanford.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2026 | 5 952 347 ( 1,72% ) | 13 M $ | 31/05/2026 |
Dernières actualités sur David Chang
Postes actifs de David Chang
| Sociétés | Poste | Début |
|---|---|---|
| PELOTON THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/02/2018 |
| ALLOGENE THERAPEUTICS, INC. | Fondateur | 01/04/2018 |
Cell Design Labs, Inc.
 Cell Design Labs, Inc. BiotechnologyHealth Technology Develops disruptive cell-based therapies for cancer and other devastating diseases | Corporate Officer/Principal | - |
A2 Biotherapeutics, Inc.
 A2 Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops cell therapies for cancer treatment | Directeur/Membre du Conseil | - |
Vida Ventures LLC
 Vida Ventures LLC Investment ManagersFinance Acts as Venture Capital Fund | Directeur/Membre du Conseil | 01/11/2017 |
Two River Consulting LLC
 Two River Consulting LLC Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Corporate Officer/Principal | 01/10/2017 |
Two River Group Holdings LLC
 Two River Group Holdings LLC Investment ManagersFinance Two River Group invests in companies located in the United States. The firm focuses on life sciences and healthcare sectors. It participates in early stage capital requirements. | Private Equity Investor | - |
VV Manager LLC
 VV Manager LLC Investment ManagersFinance Vida Ventures invests in companies located in the United States. The firm targets companies operating in the life science, healthcare, medicine, and biotechnology sectors. It provides financing for seed, early, and later stage capital requirements. | Consultant / Advisor | - |
1200 Pharma LLC
 1200 Pharma LLC Pharmaceuticals: MajorHealth Technology Provides pre-clinical drug discovery and clinical approval services | Directeur/Membre du Conseil | 01/06/2021 |
Anciens postes connus de David Chang
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░ ░░░░░░ ░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de David Chang
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
90
Relations au 1er degré
16
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 16 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Two River Group Holdings LLC
Two River Group Holdings LLC Investment ManagersFinance Two River Group invests in companies located in the United States. The firm focuses on life sciences and healthcare sectors. It participates in early stage capital requirements. | Finance |
Peloton Therapeutics, Inc.
 Peloton Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which engages in developing and researching drugs for cancer patients | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Kite Pharma, Inc.
 Kite Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company which engages in the development of novel cancer immunotherapeutic products | Health Technology |
David Geffen School of Medicine
 David Geffen School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Two River Consulting LLC
Two River Consulting LLC Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Commercial Services |
Cell Design Labs, Inc.
Cell Design Labs, Inc. BiotechnologyHealth Technology Develops disruptive cell-based therapies for cancer and other devastating diseases | Health Technology |
Vida Ventures LLC
Vida Ventures LLC Investment ManagersFinance Acts as Venture Capital Fund | Finance |
1200 Pharma LLC
1200 Pharma LLC Pharmaceuticals: MajorHealth Technology Provides pre-clinical drug discovery and clinical approval services | Health Technology |
VV Manager LLC
VV Manager LLC Investment ManagersFinance Vida Ventures invests in companies located in the United States. The firm targets companies operating in the life science, healthcare, medicine, and biotechnology sectors. It provides financing for seed, early, and later stage capital requirements. | Finance |
Allogene Therapeutics, Inc.
 Allogene Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage immuno-oncology | Health Technology |
A2 Biotherapeutics, Inc.
A2 Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops cell therapies for cancer treatment | Commercial Services |
Notch Therapeutics, Inc.
 Notch Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops cell therapies for the treatment of diseases | Health Technology |
IconOVir Bio, Inc.
 IconOVir Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops oncolytic virus therapy to improve the treatment of patients with cancer | Health Technology |
